 Don’t miss our top 5 cancer-related stories this month,
including a guest commentary from an industry leader, our two-part series on
trends in cancer research and more!
By E. Kevin Hrusovsky, PerkinElmer Inc. As the complexity and volume of data continue to rise, bioinformatics is emerging as one of the cornerstones of personalized medicine, from enabling discovery and development of novel treatments and diagnostics to facilitating collection, analysis and interpretation of data that ultimately helps an individual patient. SPECIAL REPORT PART 1: ‘Good enough’ is no longer good enough By Randall Willis, ddn Features Editor Aiming beyond the standard of care in oncology By Randall Willis, ddn Features Editor Are we really making things better for cancer patients? High-profile oncology partnership By Jim Cirigliano, ddn Contributing Editor Araxes Pharma and Janssen Biotech ink oncology drug development deal Natural neighbors By Kelsey Kaustinen, ddn Features Editor OSU, Biosortia link up to identify natural products for potential cancer treatments  |
 Horizon Diagnostics, UK NEQAS announce strategic partnership
March 2012
SHARING OPTIONS:
“We look forward to seeing our genetically defined reference
standards adopted in proficiency schemes and as batch controls, ultimately
helping to improve the accuracy of diagnostic testing for patients,” said Dr.
Paul Morrill, commercial director for Horizon Discovery, in a statement. Back |
       |
||
|
 
 
|
 |
© Copyright 2013 Old River Publications LLC. All righs reserved. | Web site managed and designed by OffWhite.